Blog - Page 3816 of 5434

MondaySep 28, 2009 1:06 pm

Clenergen Corp. (CRGE.OB) Has an Outstanding Group of Directors and Scientific Advisors

Clenergen Corp. has developed a unique system of co-gasification and localized plantation management using proprietary and mixed biomass feedstocks to implement sustainable supplies of clean energy to regional, independent clients and national electric grids. The “distributed environmental power system” or DEPS combines significant proprietary advancements in plant science with proven, long-standing engineering technologies to achieve the goal of renewable and sustainable supplies of electricity. Clenergen has an absolutely outstanding group of scientific advisors and non-executive directors to guide them on a path to future success. Here is a brief overview of the group: Dr. N. Barathi – Biotechnology Science Advisor…

MondaySep 28, 2009 12:03 pm

Stream Global Services Inc. (OOO) Customer Service is Not Dead

As the world economy begins to find its footing after recent economic events, companies are increasingly looking at costs and how to reduce and control them. In past years, capital was cheap and many institutions let capital flow with little regard for cost controls. Although this was poor judgment, it was nonetheless common practice. Today, however, cost controls are a very much needed necessity to be accomplished in a variety of ways. A company that can aide in achieving these goals is one that could be very profitable. As this reality settles in, these types of companies will become more…

MondaySep 28, 2009 10:53 am

Helicos BioSciences Corp. (HLCS) Partners with Correlagen Diagnositcs Inc. to Provide Enhanced DNA-Assays

Life science company Helicos BioSciences Corp. focuses on genetic analysis technologies for the diagnostic market. The company today announced the sale of a system and relative collaboration with Correlagen Diagnostics Inc., a leader in genetic testing for disease diagnosis. Correlagen is a Clinical Laboratory Improvement Amendments (CLIA) certified laboratory. The company will purchase and use the Helicos Genetic Analysis System for testing based on resequencing broad panels of genes found to contribute to diseases in the areas of cardiology, endocrinology, neuropsychiatry and immunology, to name a few. “We are very excited to have Correlagen as both a customer and collaborator,…

MondaySep 28, 2009 10:52 am

Consorteum Holdings, Inc. (CSRH.OB) Grows Its Role as Key Player in Payments and Transaction Processing Industry

In a world of grand and often exaggerated mission statements, Consorteum Holdings Inc. has a simple but impressive business strategy: to continually build on its extensive expertise in the payments and transaction processing industry around the world. The company aims to increase revenues in its current markets, as well as enter new markets, by delivering unique transaction and payment products and services. A major new part of this plan was revealed recently with Consorteum’s announcement that it has created a new division within the company, focusing on providing financial services to consumers and employees in both the public and private…

MondaySep 28, 2009 10:13 am

Pacific Biometrics, Inc. (PBME.OB) Announces Record Financial Results for FY2009

Pacific Biometrics, Inc. today reported to investors its operating results for FY2009. For the twelve months ended June 30, 2009 (FY2009), the company generated a record $10,881,107 in revenues, a 32% increase compared to a year earlier. Operating income improved to $613,430, compared with an operating loss of $566,026. FY2009 net income totaled $1,235,947, or $0.07 per basic and $0.06 per diluted share, compared with a FY2008 net loss of $571,429, or $0.03 per share. "While the nature of our business is subject to numerous uncertainties surrounding the ongoing consolidation within the pharmaceutical industry, the availability of capital for biotech…

MondaySep 28, 2009 10:07 am

Vision Industries Corp. (VIIC.OB) Announces Distribution Agreement with Two New Companies

Vision Industries Corp., producers of the zero emission plug-in electric/hydrogen fuel cell Tyrano™ truck, announced this morning that it has entered into a distribution agreement with Los Angeles Freightliner and Velocity Vehicle Group. Los Angeles Freightliner has agreed to be an authorized dealer of the Tyrano™ truck within the territory described as Southern California, and Los Angeles Freightliner will administer all product warranties, services and repairs programs. Brad Fauvre, President of Los Angeles Freightliner stated, “We would like to commend Vision on its hydrogen hybrid truck and their commitment to the use of the cleanest available alternative fuel trucks to…

MondaySep 28, 2009 10:03 am

Micromem Technologies, Inc. (MMTIF.OB) Enters Breast Cancer Detection Market

Micromem Technologies Inc. is a leader in magnetic random access memory (MRAM) technology for use in aerospace/defense, sensors and RFID applications. The company and its wholly-owned subsidiary, Micromem Applied Sensor Technologies Inc. (MAST Inc.), has received an initial purchase order for its sensors from Life Medical Technologies Inc. Upon completion, the order will total $30 million. Micromem anticipates delivery to begin in 2009 with the bulk expected in 2010, in accordance with fulfilling Life Medical Technologies' client orders. The initial terms of the purchase order are a request for up to 10 million units and MAST to complete a design,…

MondaySep 28, 2009 8:44 am

Cepheid (CPHD) Announces FDA-Clearance for Global Marketing of Blood Clot Test

Cepheid, a diagnostics company focused on the biothreat market, last week made a joint announcement with Instrumentation Laboratory (IL), a worldwide developer, manufacturer and distributor of vitro-diagnostics instruments, reporting that Cepheid has received clearance from the U.S. Food & Drug Administration (FDA) to market its Xpert(R) HemosIL(R) FII & FV test. According to the Centers for Disease Control and Prevention (CDCP), between 300,000 and 600,000 people have deep-vein thrombosis, or blood clots; additionally, 5 percent to 8 percent of people have thrombophilia, a condition leading to increased risk of thrombosis. Cepheid’s Xpert HemosIL FII and FB test detects thrombophilia, delivering…

MondaySep 28, 2009 8:40 am

ERF Wireless (ERFW.OB) Obtains FCC Approval

ERF Wireless, a leading provider of enterprise-class wireless broadband products and services, announced Friday that the company obtained FCC approval for 90 WiMAX 3.65-GHz transmission locations. These locations will provide broadband coverage for strategic domestic oil and natural gas development and production areas. These areas were targeted by ERF Wireless to enhance their technology, development, and growth within this sector. Specifically, this new technology is poised to make broadband services available to almost 30,000 square miles of additional energy exploration and production geography. Mr. Mike Jones, CTO of ERF Wireless, stated, “We are excited about this deployment of WiMAX technology.…

MondaySep 28, 2009 8:38 am

Versa Card, Inc. (IGLB.OB) Provides Update for Its Spine Treatment Centers

Versa Card, Inc., a developmental stage spinal solutions company doing business as “Spine Pain Management, Inc.,” recently announced that the company has opened its first spine treatment center in Houston, Texas. Omar Vidal, M.D., a fellowship-trained pain management doctor and independent contractor for the company, has initiated treatment protocols for spinal injuries resulting from automobile and work-related accidents. Dr. Vidal has serviced a number of patients, reflecting the need for spinal services in the Houston area. In the first 30 days, Dr. Vidal performed more than 25 spine procedures and the company anticipates that the number of patients treated and…

Site Search

Company Search